Articles by Priya Nori, MD
The NARROWS framework, developed within the IDSA Core Antimicrobial Stewardship Curriculum, provides a structured, behaviorally informed approach to communication that helps stewardship teams address the social, emotional, and cultural factors influencing prescribing decisions in order to optimize antimicrobial use and combat resistance.
Practice Pearls for Treatment of Respiratory Infections
ByTina Tan, MD,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP,Priya Nori, MD,Jacinda C. Abdul-Mutakabbir, PharmD, MPH,Kevin Michael Reiter, MD, PA Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.
Patient Hesitancy to Respiratory Infection Vaccines
ByTina Tan, MD,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP,Priya Nori, MD,Jacinda C. Abdul-Mutakabbir, PharmD, MPH,Kevin Michael Reiter, MD, PA Experts address patient hesitancy around both COVID-19 and influenza vaccines.
Community Education of Respiratory Infection Vaccines
ByTina Tan, MD,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP,Priya Nori, MD,Jacinda C. Abdul-Mutakabbir, PharmD, MPH,Kevin Michael Reiter, MD, PA Jacinda Abdul-Mutakabbir, PharmD, comments on building trust with community members and educating people about respiratory infection vaccines.
Encouraging Symptomatic Patients to Get Tested for Respiratory Infections
ByTina Tan, MD,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP,Priya Nori, MD,Jacinda C. Abdul-Mutakabbir, PharmD, MPH,Kevin Michael Reiter, MD, PA Experts share their approach to encouraging patients with symptoms of respiratory infections to get tested and vaccinated, and how that helps to control the spread of sickness.
Patient and Provider Education for Respiratory Infection Testing Modalities
ByTina Tan, MD,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP,Priya Nori, MD,Jacinda C. Abdul-Mutakabbir, PharmD, MPH,Kevin Michael Reiter, MD, PA Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, and Jacinda Abdul-Mutakabbir, PharmD, discuss what both the clinician and the patient need to know about testing for respiratory viruses.
Advantages and Limitations of Available Testing Modalities for Respiratory Infections
ByTina Tan, MD,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP,Priya Nori, MD,Jacinda C. Abdul-Mutakabbir, PharmD, MPH,Kevin Michael Reiter, MD, PA Priya Nori, MD, comments on the use of at-home tests for respiratory disease, including for COVID-19 and influenza.
MOA of Testing Platforms for Respiratory Infections
ByTina Tan, MD,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP,Priya Nori, MD,Jacinda C. Abdul-Mutakabbir, PharmD, MPH,Kevin Michael Reiter, MD, PA Jacinda Abdul-Mutakabbir, PharmD, examines the mechanisms of action of the different respiratory viral infection tests.
Testing for Viral Respiratory Infections
ByTina Tan, MD,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP,Priya Nori, MD,Jacinda C. Abdul-Mutakabbir, PharmD, MPH,Kevin Michael Reiter, MD, PA Experts review testing recommendations for respiratory viral infections and the types of testing options available.
Treatment for Patients With Coinfection of Respiratory Infections
ByTina Tan, MD,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP,Priya Nori, MD,Jacinda C. Abdul-Mutakabbir, PharmD, MPH,Kevin Michael Reiter, MD, PA Expert panelists continue the discussion of treatment for patients with coinfection of respiratory diseases.
Coinfection of Respiratory Infections
ByTina Tan, MD,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP,Priya Nori, MD,Jacinda C. Abdul-Mutakabbir, PharmD, MPH,Kevin Michael Reiter, MD, PA Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, comment on the overlap of respiratory infections and their approach to getting people treatment.
Overview of the Different Types of Respiratory Infections
ByTina Tan, MD,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP,Priya Nori, MD,Jacinda C. Abdul-Mutakabbir, PharmD, MPH,Kevin Michael Reiter, MD, PA Experts provide an overview of the clinical presentations of respiratory infections such as COVID-19, influenza, and respiratory syncytial virus.
Patient Populations at Greater Risk of Contracting Respiratory Viruses
ByTina Tan, MD,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP,Priya Nori, MD,Jacinda C. Abdul-Mutakabbir, PharmD, MPH,Kevin Michael Reiter, MD, PA Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, discuss patient populations that are at greater risk of contracting and suffering from complications related to respiratory viruses.
